Clinical Trial Update: Effect of Pegvisomant on GH/IGF-I Relationship in GHD [NA]

View source ↗

Summary

The clinical trial evaluating the effect of pegvisomant on the GH/IGF-I relationship in adults with adult growth hormone deficiency has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency

Drugs mentioned

• Somavert (pegvisomant)

Snippet

Sponsor: The Christie NHS Foundation Trust | Conditions: Severe Adult Growth Hormone Deficiency | NA | Status: TERMINATED